Revealing the roles of TLR7, a nucleic acid sensor for COVID-19, in pan-cancer

Danmark Nyheder Nyheder

Revealing the roles of TLR7, a nucleic acid sensor for COVID-19, in pan-cancer
Danmark Seneste Nyt,Danmark Overskrifter
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

Researchers have discovered toll-like receptor 7 (TLR7), a nucleic acid sensor within the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, to be aberrantly expressed in many types of cancers. However, its expression pattern across cancers and association with COVID-19 (or its causing virus SARS-CoV-2) has not been systematically studied.

Coronavirus disease 2019 is a disease mainly characterized by damage to the respiratory system caused bycoronavirus 2 . Recent studies suggest that cancer was a risk factor for coronavirus disease 2019 .

In this study, the authors of this article employed a computational framework to comprehensively study the roles of TLR7 in COVID-19 and pan-cancers at genetic,, protein, epigenetic, and single-cell levels. As a result, they found TLR7 expression to be higher in the lungs of mice infected with SARS-CoV-2 than in those of the control group.

This study reveals the roles of TLR7, a nucleic acid sensor for COVID-19 in pan-cancer. These findings could be significant in efforts to prevent SARS-CoV-2 infection and alleviate cytokine storms in infected cancer patients.Zhijian Huang et al, Revealing the roles of TLR7, a nucleic acid sensor for COVID-19 in pan-cancer,

Vi har opsummeret denne nyhed, så du kan læse den hurtigt. Hvis du er interesseret i nyheden, kan du læse hele teksten her. Læs mere:

medical_xpress /  🏆 101. in UK

Danmark Seneste Nyt, Danmark Overskrifter

Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammationPotential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammationResearchers report that convalescent plasma treatment is most effective in treating hospitalized COVID-19 patients.
Læs mere »

Neanderthals, environment, and evolution behind SARS-CoV-2 immune responsesNeanderthals, environment, and evolution behind SARS-CoV-2 immune responsesResearch led by the Université Paris Cité, CNRS, France, has investigated factors driving variability in diverse immune responses to SARS-CoV-2.
Læs mere »

Researchers develop new rapid and reliable method for SARS-CoV-2 detectionResearchers develop new rapid and reliable method for SARS-CoV-2 detectionCommercially available mass spectrometers can reliably detect the SARS-CoV-2 coronavirus. In the journal 'Clinical proteomics' researchers from the Martin Luther University Halle-Wittenberg (MLU) present a new method which employs equipment that is already being used in hospitals and laboratories to detect bacterial and fungal infections.
Læs mere »

Study: The human body may possess a secret weapon against SARS-CoV-2Study: The human body may possess a secret weapon against SARS-CoV-2An obscure class of molecules, part of the vast system that helps the human body distinguish 'self' from 'non-self,' may also hold the key to stopping SARS-CoV-2 from commandeering healthy cells, scientists have found in an elegant series of experiments.
Læs mere »

Quantitative biological strategy helps upgrade vaccines against COVID-19Quantitative biological strategy helps upgrade vaccines against COVID-19Researchers from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences (CAS) and the University of Hong Kong, along with their collaborators, have proposed a promising quantitative biological strategy for dynamic updates of vaccines against SARS-CoV-2 virus. They demonstrated that a vaccine based on the ancestral SARS-CoV-1 strain could offer more extended and broader protection than other options.
Læs mere »

Study suggests antibodies triggered by COVID-19 mRNA vaccination may depend on prior infection historyStudy suggests antibodies triggered by COVID-19 mRNA vaccination may depend on prior infection historyResearchers evaluated distinct immune responses to mRNA and vector-based COVID-19 vaccines and natural SARS-CoV-2 infections.
Læs mere »



Render Time: 2025-04-06 02:33:30